Back to results
UnknownPhase 3

Effect of Hydralazine on Alzheimer's Disease

NCT04842552

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Adineh Health Centre

Yazd, Iran

Contact

Masoud Mirzaei, MD, PhD

+98-913-4509917mmirzaei@ssu.ac.ir
View on ClinicalTrials.gov
Effect of Hydralazine on Alzheimer's Disease — TrialFind